New approaches to uncover COPD pathobiology and develop therapies

Area of Science:

• Pulmonary Medicine
• Genetics
• Environmental Health

Background:

• Chronic obstructive pulmonary disease (COPD) was the third leading cause of global mortality in 2011.
• Despite its impact, COPD receives limited attention and research funding.
• Understanding COPD pathogenesis requires integrating diverse factors.

Purpose of the Study:

• To review current knowledge on COPD risk factors.
• To highlight advancements in understanding molecular mechanisms of COPD.
• To emphasize the need for early diagnosis and biomarker discovery for novel therapeutics.

Main Methods:

• Review of current knowledge on COPD risk factors.
• Integration of genetic, epigenetic, microbiome, and environmental data.
• Application of advanced technologies like single-cell transcriptomics, metabolomics, and proteomics.

Main Results:

• Identification of genetic and epigenetic determinants of COPD.
• Understanding interactions between host factors, microbiome, and environmental exposures.
• Refinement of preclinical models for COPD research.

Conclusions:

• Accelerating the development of novel and effective therapeutic interventions for COPD is crucial.
• Translating new findings into clinical trials requires robust patient cohorts and early diagnostic approaches.
• Multidisciplinary collaboration through platforms like COPD-iNET is essential for advancing COPD research.